<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute for Ageing and Health</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AF1D7ABA-67D6-4979-8C08-7C0F7DE524CF"><gtr:id>AF1D7ABA-67D6-4979-8C08-7C0F7DE524CF</gtr:id><gtr:firstName>Shamima</gtr:firstName><gtr:surname>Rahman</gtr:surname><gtr:orcidId>0000-0003-2088-730X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C727E2B0-A636-4F29-9D0B-6D423A91FE19"><gtr:id>C727E2B0-A636-4F29-9D0B-6D423A91FE19</gtr:id><gtr:firstName>Doug</gtr:firstName><gtr:surname>Turnbull</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/91681F06-FB0C-421D-A8E0-A8D14BDA464F"><gtr:id>91681F06-FB0C-421D-A8E0-A8D14BDA464F</gtr:id><gtr:firstName>Joanna</gtr:firstName><gtr:surname>Poulton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1F5F95F6-2AE5-4721-A08E-53EBD12C47D9"><gtr:id>1F5F95F6-2AE5-4721-A08E-53EBD12C47D9</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B6EFF9E5-B4EE-43F8-A49B-E2ED55DE93B2"><gtr:id>B6EFF9E5-B4EE-43F8-A49B-E2ED55DE93B2</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Chinnery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B6B5BD4C-762D-47E9-9174-B30137F85B33"><gtr:id>B6B5BD4C-762D-47E9-9174-B30137F85B33</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>McFarland</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800674"><gtr:id>45DE82F8-B253-4474-806F-1588BECCB610</gtr:id><gtr:title>The MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800674</gtr:grantReference><gtr:abstractText>Mitochondria are found in every cell in the body and function like tiny batteries, converting energy locked in foodstuffs into a form that can be used easily by the cell. These tiny batteries contain their own genetic information (mtDNA) that is passed from mother to child. This genetic information is a blueprint for parts of the enzymes crucial for the energy conversion process. Genes stored in the nucleus are also important for normal mitochondrial function and disruption (misspelling or omissions in the genetic code) of either mtDNA or nuclear DNA (nDNA) can cause the batteries to fail, resulting in mitochondrial disease. This problem appears to affect at least 1 in 6500 people in the UK and commonly leads to symptoms of fatigue, weakness, unsteadiness, swallowing difficulties, stroke-like episodes, seizures, acidosis and heart disease. Recognition of mitochondrial disease as a significant clinical problem is relatively recent and many of the different forms of the disease (virtually any body organ can be affected) are still being characterized. At present no cure is available and patients? symptoms are treated with conventional medicines that have not been assessed in patients with mitochondrial disease.
We plan to define a cohort of 1500 patients, (adults and children), in whom mitochondrial disease has been identified on both clinical and genetic grounds. Our aims in developing this cohort are to translate improvements in our understanding of the science of mitochondrial disease into direct health benefits for patients. We also want to further our understanding of mitochondrial disease mechanisms and transmission and to evaluate (and optimise) the treatment of complications such as stroke, seizures, diabetes, poor growth and heart disease in patients with mitochondrial disease. The cohort will also be a rapidly accessible resource for assessing novel clinical interventions such as drugs targeted to mitochondria and exercise therapy. The cohort will be managed through The MRC Centre for Translational Research in Neuromuscular Disease and transferred to the NHS at the end of the period of funding. Data collected will be managed and stored responsibly and patient care will be unaffected by their decision to enrol in the cohort or not.</gtr:abstractText><gtr:technicalSummary>Mitochondrial disease is a severely debilitating and often life-threatening condition with a minimum prevalence of 9.2/100000 and a further 16.5/100000 at risk of developing the disease. Neuromuscular symptoms are common and developing new treatments is a key component of the recently established MRC Centre for Translational Research in Neuromuscular Disease. The clinical phenotype is extremely variable and descriptions of the natural history are largely anecdotal with no systematic attempts to study mitochondrial disease progression in a tightly defined patient cohort. The development of both retrospective and prospective assessment tools, by the Newcastle Mitochondrial Research Group, will permit acquisition of accurate objective data on mitochondrial disease progression in both children and adults from the proposed cohort. This data will be crucial in terms of providing evidence based prognostic advice to patients and is a prerequisite for assessing efficacy of clinical interventions. Trials of potential treatments for mitochondrial disease have been confined to very small groups of patients and conclusions underpowered and virtually meaningless. The development of this cohort by the MRC Centre for Translational Research in Neuromuscular Disease will facilitate large-scale interventional trials of drugs and novel treatments such as sequential resistance-endurance exercise. Strategies to prevent the complications of mitochondrial disease have been empiric with no direct evidence base. This cohort will also provide the opportunity to assess various prevention strategies including those for cardiomyopathy, stroke-like episodes, migraine and epilepsy. The unprecedented access to family data including genotyping will also permit definitive studies on the transmission of mitochondrial DNA (mtDNA) mutations and related to this, the effects of mitochondrial disease on female fertility and pregnancy. The timing of this call coincides perfectly with the recent awarding to the applicant centres in Newcastle and London of National Commissioning Group (NHS) funding for Rare Mitochondrial Diseases and MRC funding for Centre for Translational Research in Neuromuscular Disease. The cohort will provide real added value to these initiatives and benefit from the close working relationships already established.</gtr:technicalSummary><gtr:fund><gtr:end>2015-08-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>716822</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with University of Edinburgh</gtr:description><gtr:id>E3943E5D-EDAE-4CEB-97EA-8C17EC0416EB</gtr:id><gtr:impact>Wright AF, Murphy MP, Turnbull DM. Do organellar genomes function as long-term redox damage sensors? Trends Genet 2009; 25: 253-61</gtr:impact><gtr:outcomeId>0510BFD249D-1</gtr:outcomeId><gtr:partnerContribution>Expertise in genetics</gtr:partnerContribution><gtr:piContribution>Expertise in mitochondrial genetics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with UCL</gtr:description><gtr:id>BA57EC51-045C-4ECC-A77E-AEEBBABA4D01</gtr:id><gtr:impact>Joint conference on Neuromuscular diseases</gtr:impact><gtr:outcomeId>5C421C91452-1</gtr:outcomeId><gtr:partnerContribution>Expertise in muscle disease</gtr:partnerContribution><gtr:piContribution>Expertise in muscle disease and sarcopenia. This is close working between two MRC Centres. Professor Hanna directs the MRC Translational Centre for Neuromuscular Disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with University of Edinburgh - Mouse Model</gtr:description><gtr:id>99AF7BBC-7DC4-471A-88C9-BF15EB944187</gtr:id><gtr:impact>Coltman R et al. Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging, in press.</gtr:impact><gtr:outcomeId>28720FA9958-1</gtr:outcomeId><gtr:partnerContribution>Characterisation of mouse models of brain hypoperfusion</gtr:partnerContribution><gtr:piContribution>This collaboration is with Dr K Horsburgh of the Centre for Cognitive Ageing and Cognitive Epidemiology. Expertise in characterisation of the neuropathological changes in a mouse model of cerebral hypoperfusion. The collaboration is expected to lead to the development of another mouse model on site within the CBAV.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mitochondrial Biology Unit</gtr:department><gtr:description>Collaboration with Mitochondrial Biology Unit</gtr:description><gtr:id>62C1D2AE-091C-4EFD-A186-5E366228483C</gtr:id><gtr:impact>We co-chaired an international workshop (163rd ENMC International Workshop: Nucleoid and nucleotide biology in syndromes of mitochondrial DNA depletion myopathy. 12-14 December 2008, Naarden, The Netherlands) resulting in 2 publications. Cross-ferlisation of ideas result in a PLOS-genetics paper in 2010 and a Nucleic Acids Research paper in 2009.</gtr:impact><gtr:outcomeId>ZQMW18Nspaj-1</gtr:outcomeId><gtr:partnerContribution>Ian has provided reagents advice and expertise for many years</gtr:partnerContribution><gtr:piContribution>I provide him with ideas and patient materials.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with University of Texas</gtr:description><gtr:id>459B83F8-0661-4725-B494-9F72D090C298</gtr:id><gtr:impact>Murphy JL, Blakely EL, Schaefer AM, He L, Wyrick P, Haller RG, Taylor RW, Turnbull DM, Taivassalo T. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 2008a; 131: 2832-40. Multidisciplinary involving exercise phsyiology, clinical and molecular genetics</gtr:impact><gtr:outcomeId>5B879F906E6-1</gtr:outcomeId><gtr:partnerContribution>Exercise physiology</gtr:partnerContribution><gtr:piContribution>Analysis of muscle biopsies from patients undergoing exercise regimes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Collaboration with Harvard University</gtr:description><gtr:id>2A6BC8FD-DAF4-469C-A350-8AD95007F7D5</gtr:id><gtr:impact>Greaves LC, Beadle NE, Taylor GA, Commane D, Mathers JC, Khrapko K, Turnbull DM. Quantification of mitochondrial DNA mutation load. Aging Cell 2009a; 8: 566-72. Multidisciplinary involving molecular genetics, cell biology</gtr:impact><gtr:outcomeId>B78793B781E-1</gtr:outcomeId><gtr:partnerContribution>Expertise in single molecule PCR</gtr:partnerContribution><gtr:piContribution>Analysis of single cells, laser microdissection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Elders Council Radio interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>089DD084-A00E-4CF9-B45A-05FB3B3E8BBA</gtr:id><gtr:impact>Dr Gorman was interviewed for the Elders Council radio programme on a local Newcastle radio station about why an active lifestyle and its relationship to older people's quality of life, with particular reference to the effect of physical activity on cognitive ability.

not known</gtr:impact><gtr:outcomeId>LSWY8zvTGdD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BPNA</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6EBE8C30-8243-48A1-B1C5-2DB5BB1A49CB</gtr:id><gtr:impact>Plenary talk

Increased patient referrals</gtr:impact><gtr:outcomeId>6F11E9AB80F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Natural History Museum display</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F996D1FE-535F-4E58-8ACC-7327C201CB83</gtr:id><gtr:impact>We mounted a very successful exhibition as part of the Science Uncovered event at the Natural History Museum in London. We put together a portable display which included many interactive stations. The display can be re-assembled and used at future events.

The display was very popular with both children and adults who visited the exhibition and led to some interesting and thought provoking discussions with members of the public. Feedback (via brief questionnaires on the evening) was very positive.</gtr:impact><gtr:outcomeId>54621d591c3427.47956297</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://conscicom.org/2014/09/10/science-uncovered-at-the-natural-history-museum-friday-26th-september-2014-1600-2230/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CLIMB Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>566EACB1-4DA3-4EFA-B884-64C2F498A447</gtr:id><gtr:impact>JP invited to give an illustrated talk to families of mitochondrial patients for 40 minutes

Personal feedback from grateful families and commendation by chief exec of CLIMB as well as chairperson. Report to appear in organisation literature.</gtr:impact><gtr:outcomeId>8CA7627D00E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>24ACDAB0-7CAA-4A50-8B94-8C46C6AB5718</gtr:id><gtr:impact>A website (http://www.mitochondrialncg.nhs.uk) for both patient and health professional use. This is to increase awareness and knowledge of the disease and disseminate good practice.

This website is providing information for clinicians about referral and diagnostic options for patients not currently seen at a specialist centre. Likewise, patients are also able to find out about options, and also to gain knowledge and information about their condition.</gtr:impact><gtr:outcomeId>D1CED45841E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newcastle University engagement activities</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4DC3FD15-6F21-415E-8151-8AE84EABCFC2</gtr:id><gtr:impact>The Centre continues to provide funding towards the salary of Newcastle University's Public Engagement Team. The University has a broad programme of engagement activities. Over the last 12 months there have been over 15 events aimed at disseminating the University's research and activity to the general public. They communicate the activities of CBAV on a monthly basis through Voice North (the Regional Engagement Panel made up of a group of over 700 people reflecting the ag- structure and geographical and socioeconomic make-up of the North East) communications and events and through Years Ahead, the North East Regional Forum on Ageing.

The activities of the public engagement team raise awareness of the research being undertaken by the Centre and the University as a whole. Voice North provides focus groups which contribute to the development of research projects and provide participants for research projects.</gtr:impact><gtr:outcomeId>reS4JvYq9Wh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nuffield students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>07482677-026E-4C41-9634-BD03F2C69DC9</gtr:id><gtr:impact>3 students, who were interested in following science as a career, had successfully applied to the Nuffield Foundation for work placements. At the request of the Nuffield Foundation, we were very happy to welcome them into our labs. They spent several weeks in the lab gaining hands-on experience of research.

At the end of their time in the lab, both the students and ourselves produced a report on the experience which was submitted to Nuffield.</gtr:impact><gtr:outcomeId>54621ee99a5842.13462648</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.nuffieldfoundation.org/nuffield-research-placements</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Information Event Gateshead</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C9AC7DCE-18E6-4836-8881-FA5703E50493</gtr:id><gtr:impact>One of the Principal Investigators on the project participated at a Patient Information Event held in Gateshead in June 2010/

not known</gtr:impact><gtr:outcomeId>nHBSdc7Uqro</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Information Day - London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C84A2DDF-5DC9-4D7D-8E0D-1386809646D4</gtr:id><gtr:impact>A Patient Information Day was held in London for local patients, carers and relatives. The day included discussion about the cohort and how patients could get involved.

A number of patients were recruited to the study as a result of the information day, and awareness of the cohort study in general was increased.</gtr:impact><gtr:outcomeId>6CD6BE44936</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newcastle Science Festival 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>52359BF2-F406-4323-B6A6-63A4055A0FD7</gtr:id><gtr:impact>Presented a poster entitled, &amp;quot;Should you put all your eggs in one basket? Fitting another piece to the Parkinson's disease puzzle.&amp;quot; Attendees asked questions and discussed the findings.

not known</gtr:impact><gtr:outcomeId>fK9NQvxtsby</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fit as a Falcon</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AB7E5170-82DC-48F2-94FF-5D747E57AE37</gtr:id><gtr:impact>An activity day attended by over 100 school children showcasing the four themes of the Centre. The day was organised in collaboration with Newcastle Falcons Community Foundation and built on work they were already doing with schools in the area. The activities were designed to show how a healthy lifestyle when we are younger affects the way we age, focusing on exercise and nutrition.
Feedback from the children, teachers and students and scientists involved in the event was very positive. It also worked well from the Falcons perspective and they have asked us to make this an annual event. There will also be opportunities to be involved with other engagement programmes that the Falcons Community foundation are running.</gtr:impact><gtr:outcomeId>58a6d87238e667.29125340</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OK to ask campaign</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E73E881B-2745-4252-B0F4-394209E13C52</gtr:id><gtr:impact>The NIHR 'Ok to ask' campaign aims to encourage patients or carers to ask about research opportunities that could be available to them or their families. We took part in this campaign by holding a stall outside of the Medicinema within the The Great North Children's Hospital. It gave members of the public an informal opportunity to chat to some of our researchers and ask questions about our research.</gtr:impact><gtr:outcomeId>58c7d3d730d394.23450144</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.newcastle-mitochondria.com/ok-to-ask-campaign-2/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Information Day - Newcastle</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>99E334BC-D47F-420F-9310-EE1F06E8C13B</gtr:id><gtr:impact>A patient information day for patients, carers and relatives. This gave information on a range of subjects related to mitochondrial disease, with a specific section of the day devoted to providing information about this cohort.

We were able to recruit a number of patients as a result of the information provided, and raised awareness of the cohort in the patient gorup.</gtr:impact><gtr:outcomeId>0AD5460BA8A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Information Evening</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>67E297E7-4D0E-4745-A5EB-20F17FC23B05</gtr:id><gtr:impact>I organised and obtained finance for an information day for patients with mitochondrial DNA diseases. As well as chairing the meeting I gave a 30 minute talk to a lay audience

High patient satisfaction score on subsequent questionaire and complements from professionals who attended</gtr:impact><gtr:outcomeId>6D0568129FE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DMT Max Planck Cologne</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C4AD4DD8-9CA2-4557-B7D1-FD57756569D1</gtr:id><gtr:impact>Keynote speech at the Max Planck Institute Symposium in Cologne. Talk generated a lot of questions and discussion.

continued collaboration with researchers at the Max Planck Institute</gtr:impact><gtr:outcomeId>5460ac14c0ed07.77265940</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Response to Science comment article on mitochondrial transfer</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1DA737B7-9792-430F-830C-D6C588094E06</gtr:id><gtr:impact>The article on the mitochondrial transfer technique sparked a media frenzy with articles appearing in many newspapers and magazines worldwide as well as extensive coverage on TV, radio and the internet. Below is a selection of items.
http://www.sciencemediacentre.org/tag/mitochondrialdna/
http://theconversation.com/viewpoints-the-promise-and-perils-of-three-parent-ivf-18402
http://www.bbc.co.uk/news/health-24158049
BBC News (quotes Robin LovellBadge and Doug Turnbull)
http://www.bbc.co.u

The extensive media coverage has increased awareness of mitochondrial disease and we have received an increased number of enquiries and hits on our website.</gtr:impact><gtr:outcomeId>546200fe4d3a77.29905435</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pronuclear paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4FAE5E99-7F36-42FE-B5FA-F571DC78E1CA</gtr:id><gtr:impact>The publication of this paper in April 2010 generated a huge amount of media interest both nationally and inernationally.
Articles appeared in the following newspapers: The Times - page 15 http://tinyurl.com/y625ewj; Daily Mail - page 4 http://tinyurl.com/y5wr6x8; The Telegraph - page 1 http://tinyurl.com/y62t89o; The Guardian - page 1 http://tinyurl.com/y3u4g3m; The Express - page 7 http://tinyurl.com/yyanlh6; Financial Times - page 4 http://tinyurl.com/y6kw2qo; The Sun - page 4 http://tinyurl.com/y6f96cu (The Mirror - page 22 http://tinyurl.com/y6mm3fa

There was also extensive coverage on radio and television, most notably: The story led the Six O'clock news with a 5-minute slot; Sky News ran the story all night; Channel Four did a nice piece and a mention on the ITV news. There were slots on Radio 5 Live and the Today programme and mentions on 
most BBC regional stations.

The story was also reported by the following international organisations: ABC News
CBC (Canada)
Globe and Mail (Canada)
MSNBC/ NBC
San Francisco Chronicle
BBC News
Daily Mail
Daily Telegraph
Financial Times
Guardian
Herald
Independent
Sun
Times
AFP (France)
Bloomberg
EFE (Spain)
Reuters
UPI
Xinhua (China)
ABC (Australia)
The Australian
Sydney Morning Herald
China Daily
People's Daily (China)
Spiegel (Germany)
Corriere della Sera (Italy)
La Repubblica (Italy)
Times of India



HFEA launched a public consultation into the ethics of pronuclear research in 2012.</gtr:impact><gtr:outcomeId>BCAqBeaS2Xu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient information day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9247A788-854B-4BC8-9CA6-498AF99ADEBF</gtr:id><gtr:impact>84 patients and their families atended an information day covering research and clincial needs. The Cohort study was mentioned and patients were invited to join the cohort.
The session was recorded and placed on YouTube

Questionnaires at end of session showed great support for such a day</gtr:impact><gtr:outcomeId>KuVBRn6PeTb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Centre for Mitochondrial Research</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>096919</gtr:fundingRef><gtr:id>28F722DC-5F99-4739-8C66-77D0089D966B</gtr:id><gtr:outcomeId>dL173f7pfHn0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>724428</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mitochondrial Disease Patient Cohort (UK)</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>280CE64A-DBA9-427C-AFD2-404F33A69DE0</gtr:id><gtr:outcomeId>F57084046D50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>625</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Keystone Scholarship/National Institutes of Health, National Institute on Aging Grant #1R13AG034755-01.</gtr:description><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>640B8B00-6EFA-422C-86C3-51D4784ECAF7</gtr:id><gtr:outcomeId>J4asHTFHrGg0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>759103</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Exercise Lab</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802536</gtr:fundingRef><gtr:id>89B4D0FB-E2A7-4D67-BEEC-AAA141258E6F</gtr:id><gtr:outcomeId>5BB485E390D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>55FE6F47-3A06-4DB8-B7BA-7403331AB84C</gtr:id><gtr:outcomeId>21AA5156CE40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242206</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cardiac manifestations of mitochondrial disease - incidence, mechanisms and treatment</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>British Psychological Society (BPS)</gtr:fundingOrg><gtr:id>DDA9C8C7-A57E-4542-A07B-C6482F7DD6A1</gtr:id><gtr:outcomeId>0DC942B0C490</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>73430</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>In situ characterisation of stem cells and their fate in the human prostate (co-applicant)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>CA5E90F3-AA48-479C-890A-7CB508F60053</gtr:id><gtr:outcomeId>dMBQy9G6h9S0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>957958</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre for Neuromuscular Diseases</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>K000608</gtr:fundingRef><gtr:id>6F664DD8-603D-4848-8510-7F493801766C</gtr:id><gtr:outcomeId>546237ed847a55.55122058</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>244514</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical training fellowship</gtr:description><gtr:fundingOrg>Royal College of Psychiatrists</gtr:fundingOrg><gtr:id>8655CC14-DE5F-4D07-A137-A5AA636A55FB</gtr:id><gtr:outcomeId>02FC0589CFB0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83787</gtr:amountPounds><gtr:country>Italy, Italian Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fondazione IRCCS Istituto Neurologico Carlo Besta - Fight MERFF Y1/Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta</gtr:description><gtr:fundingOrg>Carlo Besta Neurological Institute</gtr:fundingOrg><gtr:id>19F68ADD-6ABD-43F1-8A3B-0DECDEFE4E7E</gtr:id><gtr:outcomeId>414694FABEC0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight Alpers/The Ryan Stanford Appeal</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Ryan Stanford Appeal</gtr:fundingOrg><gtr:id>CE0033B1-24D9-4371-B231-E0660BC3FECA</gtr:id><gtr:outcomeId>AQM2QQuqtDx0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200010</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RCF - salary funding for backfill post</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>1D48FBD8-DD44-495C-892D-B50F900D0366</gtr:id><gtr:outcomeId>5460d00f2f95b1.63324295</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A questionnaire that is honed to pick up quality of life measurements in this particular patient group.</gtr:description><gtr:id>CA7B66EA-2C65-46B5-BA7D-1A92066529D5</gtr:id><gtr:impact>This evaluation will allow us to better measure quality of life in patients, and design future studies and interventions around this. We aim to develop this further before disseminating to other research and clinical settings.</gtr:impact><gtr:outcomeId>018637CD1E4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quality of Life questionnaire</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The funding is to develop a mitochondrial disease cohort. We have collected 240 patients in first year with funding to develop the cohort over the next 2 years</gtr:description><gtr:id>B3614D65-A719-4457-A0A7-690EB7FF79DB</gtr:id><gtr:impact>Collecting cohort only at this stage</gtr:impact><gtr:outcomeId>C1F24306153</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mitochondrial Disease Cohort</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D560084C-25BE-493A-87BC-954D59162093</gtr:id><gtr:title>Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9577563548c626dd95be27b3f1f57c9"><gtr:id>d9577563548c626dd95be27b3f1f57c9</gtr:id><gtr:otherNames>Murphy JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12887_27_22647770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11D7AD1A-38C7-4D7B-A110-9B43E600EC9C</gtr:id><gtr:title>The genetics and pathology of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>5a5f557986e578.13613704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591E5F97-19D2-4B16-B472-C6F7C714240B</gtr:id><gtr:title>Distal weakness with respiratory insufficiency caused by the m.8344A &amp;gt; G &amp;quot;MERRF&amp;quot; mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4ee6ba0f820764b5675e3c255fdb95a"><gtr:id>a4ee6ba0f820764b5675e3c255fdb95a</gtr:id><gtr:otherNames>Blakely EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>544e59c5a2c7d2.20539760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69E91B97-05AD-42BC-9D3C-E2E70351B9D1</gtr:id><gtr:title>Whole-genome sequencing and the clinician: a tale of two cities.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>doi_55f984984b98cd71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25A7FED-7933-4899-ABC3-A3C36CF3FD45</gtr:id><gtr:title>Clinical features of the pathogenic m.5540G&amp;gt;A mitochondrial transfer RNA tryptophan gene mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4767d613694b160a2224099a0d07c0e9"><gtr:id>4767d613694b160a2224099a0d07c0e9</gtr:id><gtr:otherNames>Ng YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>585d3538f0c016.83600083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D8FECF-0E0F-4832-8662-C3F4F7910B7C</gtr:id><gtr:title>Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers.</gtr:title><gtr:parentPublicationTitle>European heart journal cardiovascular Imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2047-2404</gtr:issn><gtr:outcomeId>544e5d18c63bf0.86151033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA298C4D-CDE5-4A6E-830B-591C16054D58</gtr:id><gtr:title>Extra-ocular muscle MRI in genetically-defined mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>585d5888c86058.65340316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38158338-81F1-4D76-80F7-935CB8F74C41</gtr:id><gtr:title>Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e5c120a5f918877256bb14fc3b93fc1"><gtr:id>2e5c120a5f918877256bb14fc3b93fc1</gtr:id><gtr:otherNames>Young TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>aBGdkCrQrkB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77311210-7237-4F55-8CB5-860FD73CA8E1</gtr:id><gtr:title>Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dc4ef98fb109882a350e079947eb003"><gtr:id>5dc4ef98fb109882a350e079947eb003</gtr:id><gtr:otherNames>Trivedi JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e15ee15e13182c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDE6B83C-7FE4-4C02-8E61-360A4D54359E</gtr:id><gtr:title>Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58a4551ceb4a92.15524150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846E4689-9041-42C8-9C8F-C4525CE4D148</gtr:id><gtr:title>Neuro-Sweet's disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb1a73967250ca578fc0fda3315e377"><gtr:id>5bb1a73967250ca578fc0fda3315e377</gtr:id><gtr:otherNames>Maxwell G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>pm_12887_27_22450461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEAD106D-BF70-41DB-8698-40E5A04BF5D4</gtr:id><gtr:title>Searching for the needle in the Haystacks.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/182b0a88854be56b9e47741557cb3c14"><gtr:id>182b0a88854be56b9e47741557cb3c14</gtr:id><gtr:otherNames>Ogundare O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>F525257FF91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED8E9924-4791-493D-937A-0228E970D917</gtr:id><gtr:title>Disease progression in patients with single, large-scale mitochondrial DNA deletions.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74f2fa9963b7ec34c3908d8b43ff9534"><gtr:id>74f2fa9963b7ec34c3908d8b43ff9534</gtr:id><gtr:otherNames>Grady JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544e59c612db85.24875248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A8C1849-B4CA-404E-9AD1-C722739AD98A</gtr:id><gtr:title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f541a42cba1539f06b619564772e9d9d"><gtr:id>f541a42cba1539f06b619564772e9d9d</gtr:id><gtr:otherNames>Craven L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>DDNXHfNhDsA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0C73ABD-B30B-4119-A981-A0ACE2472678</gtr:id><gtr:title>Maternally inherited mitochondrial DNA disease in consanguineous families.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_12887_27_21712854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E3F8CE-B28C-4535-9462-B07177F65093</gtr:id><gtr:title>COX10 mutations resulting in complex multisystem mitochondrial disease that remains stable into adulthood.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_13312_22_24100867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05C1B265-59E7-4BA4-8835-04DD12E39628</gtr:id><gtr:title>The presence of highly disruptive 16S rRNA mutations in clinical samples indicates a wider role for mutations of the mitochondrial ribosome in human disease.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>56e05d5b55fb02.66976630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41DC7E2A-0767-4CEF-AE1F-8F87888D1F24</gtr:id><gtr:title>Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells.</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fcbe089751d63ca9d3cd02742981ed6"><gtr:id>6fcbe089751d63ca9d3cd02742981ed6</gtr:id><gtr:otherNames>Lin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>58a7110534fed1.76034125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA916ADE-A562-418F-AD46-96E5308AECA9</gtr:id><gtr:title>Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b7092e8b6da59c8d5f3b11ed7d2a72"><gtr:id>72b7092e8b6da59c8d5f3b11ed7d2a72</gtr:id><gtr:otherNames>Campbell GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_12887_27_22688405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99893368-D828-4C3C-8E20-507EDE2E41FA</gtr:id><gtr:title>Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>YewTFpjhDVS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E01AD942-C422-44F0-8FF5-6C4C5044FA4B</gtr:id><gtr:title>Research into Policy: A Brief History of Mitochondrial Donation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f541a42cba1539f06b619564772e9d9d"><gtr:id>f541a42cba1539f06b619564772e9d9d</gtr:id><gtr:otherNames>Craven L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>57c01a10114469.59206391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>499FF655-5663-43EB-8550-1E3956FD05E9</gtr:id><gtr:title>Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255f14bfe5038a10c88615ffcedb9000"><gtr:id>255f14bfe5038a10c88615ffcedb9000</gtr:id><gtr:otherNames>Gr?newald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>57c01a0fe0a6e7.97065271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B14DF2-14E9-4DEF-A9B9-09C7FFAD0728</gtr:id><gtr:title>The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e326331ecce70beeda4b3a92a25dcd7"><gtr:id>2e326331ecce70beeda4b3a92a25dcd7</gtr:id><gtr:otherNames>Verity CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>oq26bUviVSX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>571C6DD1-25BF-4359-AA64-EA25E9605E57</gtr:id><gtr:title>Mitochondrial dysfunction in myofibrillar myopathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8396e53d2ca82d367005fb41ecc9ac1b"><gtr:id>8396e53d2ca82d367005fb41ecc9ac1b</gtr:id><gtr:otherNames>Vincent AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58a711048c91b0.03166780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48FB6D49-943D-43C4-9B91-B71922A2DDDA</gtr:id><gtr:title>The pathogenic m.3243A&amp;gt;T mitochondrial DNA mutation is associated with a variable neurological phenotype.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>XagqMUUPFme</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>808010C9-78CC-47FB-8482-F491CC82FCE2</gtr:id><gtr:title>Potential compounds for the treatment of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9bac13cb88cd36c6b6b986ea2e87e04"><gtr:id>b9bac13cb88cd36c6b6b986ea2e87e04</gtr:id><gtr:otherNames>Rai PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>56dee344481951.16627960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4013DB62-553A-48FA-883A-74E5181D248D</gtr:id><gtr:title>ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3594f340e4a1627490ba4eeba3e02389"><gtr:id>3594f340e4a1627490ba4eeba3e02389</gtr:id><gtr:otherNames>Sarkozy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>544e59c72c96b1.80803086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>013418C0-D1A5-40C4-8DC9-FC8DA7AF6267</gtr:id><gtr:title>A national perspective on prenatal testing for mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f5a64e763cce75d1f562606ee76e5bc"><gtr:id>7f5a64e763cce75d1f562606ee76e5bc</gtr:id><gtr:otherNames>Nesbitt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544e59c6f04a42.73311119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D04B2A59-F645-4A04-9D80-ABC900B71C72</gtr:id><gtr:title>Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts.</gtr:title><gtr:parentPublicationTitle>Experimental gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0531-5565</gtr:issn><gtr:outcomeId>d3BWcErPgpz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FCBC938-4255-4DEA-9FFC-288BA7A4680E</gtr:id><gtr:title>A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d934800bba4c6d737acf332a3f88b99e"><gtr:id>d934800bba4c6d737acf332a3f88b99e</gtr:id><gtr:otherNames>Yarham JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_12887_27_21882289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C96E412-6029-467B-ADC6-5CAB27A9BAFE</gtr:id><gtr:title>Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>GjH5faipuEk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F915641-8E05-41DF-8B82-0EB3A9E24D41</gtr:id><gtr:title>Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12887_27_22578526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46D4FA0B-4910-480A-8406-155582929624</gtr:id><gtr:title>Defining cardiac adaptations and safety of endurance training in patients with m.3243A&amp;gt;G-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>doi_55f984984b6067f6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91E2264F-E827-4F8A-AF98-697ADBA2010F</gtr:id><gtr:title>Autosomal dominant acute necrotising encephalopathy: a case report with possible disease-expression modification by coincidental homocysteinuria.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98739734e76fe49a0d1a0a9ac0ff3cbf"><gtr:id>98739734e76fe49a0d1a0a9ac0ff3cbf</gtr:id><gtr:otherNames>Gilson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>MW8HCmZiut1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>842D9CFD-3CD6-4EAB-9069-76CE6FA89B18</gtr:id><gtr:title>Targeting protein homeostasis in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af0707d338e2c1c3c05688ae01f64aed"><gtr:id>af0707d338e2c1c3c05688ae01f64aed</gtr:id><gtr:otherNames>Ahmed M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>585d5261421019.24007777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E76E1A8-251A-4E5B-8221-73A552B92174</gtr:id><gtr:title>Initial development and validation of a mitochondrial disease quality of life scale.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>doi_55f945945045764e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1BE1524-1270-4F18-ADBB-A71847DBE61C</gtr:id><gtr:title>Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase ? mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12887_27_22933815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48E0BD0-A72C-4A21-8409-7D5E307D50A7</gtr:id><gtr:title>Mitochondrial donation--how many women could benefit?</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5675df1b11c01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF40C56B-31F0-4B50-9537-6BEC8F28F797</gtr:id><gtr:title>Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>pm_12887_27_22249460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0B712EF-B5A1-474A-B71C-4BBB08949119</gtr:id><gtr:title>Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c91f13481ecffef6f93e85f05e3620a"><gtr:id>4c91f13481ecffef6f93e85f05e3620a</gtr:id><gtr:otherNames>Anagnostou ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>585d398d58fc57.63462736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60BBE015-99C2-46F7-BC17-55378CDB3E14</gtr:id><gtr:title>Clinicopathologic and molecular spectrum of-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa2a04661be48.03376357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A77C221-ECE2-49A4-A84F-AF2922150249</gtr:id><gtr:title>Mitochondrial Nanotunnels.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8396e53d2ca82d367005fb41ecc9ac1b"><gtr:id>8396e53d2ca82d367005fb41ecc9ac1b</gtr:id><gtr:otherNames>Vincent AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>5a5f5578984225.09717777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B1056FB-DBDB-46C7-A206-8D994ECFF6E2</gtr:id><gtr:title>Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12887_27_22933740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0000B826-B6BE-4516-9455-834C93EAC5A0</gtr:id><gtr:title>Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544e59c4c068f1.22279193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C421FE2-FC17-4C7A-BB2F-5F94F99ED671</gtr:id><gtr:title>Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>doi_55f984984b4cbfc5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67CA3C40-4B87-445D-B009-C2421B6898C2</gtr:id><gtr:title>Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>doi_55f984984b565d34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00CE4F24-237C-4B55-8139-F45EF60208DA</gtr:id><gtr:title>Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>doi_55f984984b8ef56d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65AFFEFA-6465-4F01-BB29-67FB71C9066E</gtr:id><gtr:title>Depressive behaviour in children diagnosed with a mitochondrial disorder.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/678b695ff02974b7b5014bd9a1dad991"><gtr:id>678b695ff02974b7b5014bd9a1dad991</gtr:id><gtr:otherNames>Morava E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>tXQwM5bhc5a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1826EFC6-B416-4242-B544-B5C8793B8875</gtr:id><gtr:title>A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>cvTuXAf115o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F461204D-4B00-41FD-8E3B-862BE9237CA0</gtr:id><gtr:title>Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98ec0d3af40a7f328ef3a0d8234f00bc"><gtr:id>98ec0d3af40a7f328ef3a0d8234f00bc</gtr:id><gtr:otherNames>Rowan SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12887_27_22235261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCA2C36-ADAC-4066-90F6-FC50844FCA1E</gtr:id><gtr:title>Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(-/-) mice.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01b8bbd659bc2658cd7e61b5045c08f9"><gtr:id>01b8bbd659bc2658cd7e61b5045c08f9</gtr:id><gtr:otherNames>Dobson PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58a711041f05c3.05354157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76544AC0-DAE7-458F-B24D-4E5DE7C8DD03</gtr:id><gtr:title>Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255f14bfe5038a10c88615ffcedb9000"><gtr:id>255f14bfe5038a10c88615ffcedb9000</gtr:id><gtr:otherNames>Gr?newald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>544e59c48eb0f9.61086507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8108A1C-78BE-467B-AB8F-718423605F67</gtr:id><gtr:title>THE MEDICAL RESEARCH COUNCIL NEUROMUSCULAR CENTRE FOR TRANSLATIONAL RESEARCH MITOCHONDRIAL DISEASE PATIENT COHORT STUDY UK: FROM CONCEPTUALISATION TO UTILISATION</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f5a64e763cce75d1f562606ee76e5bc"><gtr:id>7f5a64e763cce75d1f562606ee76e5bc</gtr:id><gtr:otherNames>Nesbitt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_13312_22_24109053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16FA40E8-DA43-4E89-A84A-89B83469D201</gtr:id><gtr:title>Epilepsy in adults with mitochondrial disease: A cohort study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56dee345088832.87310091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A6BBB45-D7D2-431F-B099-ECB7F11A0E36</gtr:id><gtr:title>Triplex real-time PCR--an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbb354db3fe15f02e9119f525c22a31a"><gtr:id>dbb354db3fe15f02e9119f525c22a31a</gtr:id><gtr:otherNames>Rygiel KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5675e4bf437ab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D7671C6-4B58-4F8D-AED3-E5F44E6DCE4F</gtr:id><gtr:title>Mitochondrial diseases in childhood: a clinical approach to investigation and management.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd62e90b92f3c507b0a9b84b6c557a11"><gtr:id>dd62e90b92f3c507b0a9b84b6c557a11</gtr:id><gtr:otherNames>Kisler JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>D18Q6eGtnab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5E05552-90AE-444D-A06F-2565F35B1038</gtr:id><gtr:title>Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12887_27_23107649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2454583F-B91F-46B5-BE4A-95DE481E8AE9</gtr:id><gtr:title>Characterization of mtDNA variation in a cohort of South African paediatric patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b92bf2e1f4d64fa7047185038515f46"><gtr:id>1b92bf2e1f4d64fa7047185038515f46</gtr:id><gtr:otherNames>van der Walt EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_12887_27_22258525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50968D8B-4121-467F-8A23-170731722518</gtr:id><gtr:title>Recent Advances in Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>Annual review of genomics and human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f541a42cba1539f06b619564772e9d9d"><gtr:id>f541a42cba1539f06b619564772e9d9d</gtr:id><gtr:otherNames>Craven L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1527-8204</gtr:issn><gtr:outcomeId>5a5f55794bf251.53039002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83402ABD-8BF6-4DBC-B8B5-7B0A27CECFE4</gtr:id><gtr:title>Mutations causing mitochondrial disease: What is new and what challenges remain?</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee62e53aa807f0b784d06e9a75e65323"><gtr:id>ee62e53aa807f0b784d06e9a75e65323</gtr:id><gtr:otherNames>Lightowlers RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5675ebef6c9db</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2242D573-8AF3-4033-ABD5-94F41F51AF4A</gtr:id><gtr:title>Childhood-onset Leber hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b59fc60f985bd8aacf9bde6a7f490cf9"><gtr:id>b59fc60f985bd8aacf9bde6a7f490cf9</gtr:id><gtr:otherNames>Majander A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>5a34f590c7de90.09239817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE2EB78-7602-4A2C-9EB6-D99C98EA168D</gtr:id><gtr:title>Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5675e598928c0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04DB8F20-7149-43B3-B31F-E6007078A70A</gtr:id><gtr:title>Naked mole-rats maintain healthy skeletal muscle and Complex IV mitochondrial enzyme function into old age.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e474c1b9f4c9752681f2586b35687d7b"><gtr:id>e474c1b9f4c9752681f2586b35687d7b</gtr:id><gtr:otherNames>Stoll EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>58a71105caf005.83244147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D98873E-20A5-43AE-889E-E06A10BEF951</gtr:id><gtr:title>Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A&amp;gt;G mutation and correlates with mutation load.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12887_27_22513320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D1B9A89-ACB2-42D4-802B-7B64629B5F61</gtr:id><gtr:title>Spectrum of Movement Disorders in Mitochondrial Disorders-Reply.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd55d049dbcc0d328614887ca48f1222"><gtr:id>fd55d049dbcc0d328614887ca48f1222</gtr:id><gtr:otherNames>Martikainen MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58a71103b53443.34248141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F60D193-A157-41BF-B6BE-725F44717D28</gtr:id><gtr:title>Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4ee6ba0f820764b5675e3c255fdb95a"><gtr:id>a4ee6ba0f820764b5675e3c255fdb95a</gtr:id><gtr:otherNames>Blakely EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15693_23_23696415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB72C52E-AB1F-43BE-9C84-90EA05A5C11C</gtr:id><gtr:title>Toward a mtDNA locus-specific mutation database using the LOVD platform.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_12887_27_22581690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5632F456-A33C-4F41-B09F-FBF53786E1EF</gtr:id><gtr:title>A p.R369G POLG2 mutation associated with adPEO and multiple mtDNA deletions causes decreased affinity between polymerase ? subunits.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4398edeed9fb60ad91212c82c21eda80"><gtr:id>4398edeed9fb60ad91212c82c21eda80</gtr:id><gtr:otherNames>Craig K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>pm_12887_27_22155748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DA63BB4-B2D9-4E3E-9F15-2AF895CD50E5</gtr:id><gtr:title>Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5964a0429e418ebcc000a3294a6f630a"><gtr:id>5964a0429e418ebcc000a3294a6f630a</gtr:id><gtr:otherNames>Zambonin JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>i2A5QtUR25P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0985C9E6-CDC8-4BC2-9DCC-02DC585D1A46</gtr:id><gtr:title>The m.3291T&amp;gt;C mt-tRNA(Leu(UUR)) mutation is definitely pathogenic and causes multisystem mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d934800bba4c6d737acf332a3f88b99e"><gtr:id>d934800bba4c6d737acf332a3f88b99e</gtr:id><gtr:otherNames>Yarham JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>doi_55f984984b72c333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50BC2035-2C61-4A2B-884E-A461B1EEB669</gtr:id><gtr:title>Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_540e15ee15e312a1a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE121ED-756C-4F62-9F40-226662191D33</gtr:id><gtr:title>Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4767d613694b160a2224099a0d07c0e9"><gtr:id>4767d613694b160a2224099a0d07c0e9</gtr:id><gtr:otherNames>Ng YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58a7110608c3c0.92938339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE8CB9FE-5AA4-4AF0-968A-5789DAF79F75</gtr:id><gtr:title>Genetic Counselling for Maternally Inherited Mitochondrial Disorders.</gtr:title><gtr:parentPublicationTitle>Molecular diagnosis &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02cbf15604f6dbeb2eec035e333b499"><gtr:id>d02cbf15604f6dbeb2eec035e333b499</gtr:id><gtr:otherNames>Poulton J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1177-1062</gtr:issn><gtr:outcomeId>5aa29ee4c78fb2.34438214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDA09332-3F8D-4F44-88F3-8309558D9AB3</gtr:id><gtr:title>The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8396e53d2ca82d367005fb41ecc9ac1b"><gtr:id>8396e53d2ca82d367005fb41ecc9ac1b</gtr:id><gtr:otherNames>Vincent AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d66c02bf775.36363786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8455554-4E12-4731-B516-14C0F0E1BA6D</gtr:id><gtr:title>Expanding Our Understanding of mtDNA Deletions.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fbb8678528f8cb634deb50d424fecf2"><gtr:id>0fbb8678528f8cb634deb50d424fecf2</gtr:id><gtr:otherNames>Picard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>58a711050a2651.90470296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A69C9F1D-ECEE-4C5D-97CA-0806D200AE0C</gtr:id><gtr:title>Using a quantitative quadruple immunofluorescent assay to diagnose isolated mitochondrial Complex I deficiency.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b9f7ca8bb4df7133446d19983c8f910"><gtr:id>8b9f7ca8bb4df7133446d19983c8f910</gtr:id><gtr:otherNames>Ahmed ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa6a97f678e25.41572169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85DCE86B-E5A7-4B90-8129-94337421DCFB</gtr:id><gtr:title>The ageing neuromuscular system and sarcopenia: a mitochondrial perspective.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbb354db3fe15f02e9119f525c22a31a"><gtr:id>dbb354db3fe15f02e9119f525c22a31a</gtr:id><gtr:otherNames>Rygiel KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>57c01a11af4197.44264241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4A5BE59-B6A0-41E2-8920-EAD93C922740</gtr:id><gtr:title>Pathogenic mitochondrial tRNA mutations--which mutations are inherited and why?</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_12887_17_19718780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E1D264-9078-40E6-8E04-2D1574507A51</gtr:id><gtr:title>Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9015226fe85aa441230a01ec3c9484"><gtr:id>fe9015226fe85aa441230a01ec3c9484</gtr:id><gtr:otherNames>Tuppen HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>eBiMdunZy5v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D53F47BD-09AD-4FF7-875E-28BC885194FB</gtr:id><gtr:title>Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.</gtr:title><gtr:parentPublicationTitle>Journal of clinical medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b4754bf379911205e39d0b4abdcad59"><gtr:id>2b4754bf379911205e39d0b4abdcad59</gtr:id><gtr:otherNames>Morovat A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2077-0383</gtr:issn><gtr:outcomeId>5a6f2d2dbb7764.93874225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96EADCD9-397E-465B-BFBC-46FFCAFDE19F</gtr:id><gtr:title>Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cffc962b932447a7204bc4603ea0b0cd"><gtr:id>cffc962b932447a7204bc4603ea0b0cd</gtr:id><gtr:otherNames>Uusimaa J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_15693_23_23714749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DD14754-A096-4A34-9562-53FE68C9CB79</gtr:id><gtr:title>Review: Central nervous system involvement in mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58a7110592df48.90988521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2090C653-F09D-4ECA-A9D4-8AEB39794569</gtr:id><gtr:title>Dysferlin mutations and mitochondrial dysfunction.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8396e53d2ca82d367005fb41ecc9ac1b"><gtr:id>8396e53d2ca82d367005fb41ecc9ac1b</gtr:id><gtr:otherNames>Vincent AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58a71104b9f1e9.75840339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7464E4C7-D24E-46B3-961A-2067435E9917</gtr:id><gtr:title>A proposed consensus panel of organisms for determining evolutionary conservation of mt-tRNA point mutations.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d934800bba4c6d737acf332a3f88b99e"><gtr:id>d934800bba4c6d737acf332a3f88b99e</gtr:id><gtr:otherNames>Yarham JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>pm_12887_27_22781547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D83CB15D-4476-4752-A6B4-4F98D509A48A</gtr:id><gtr:title>Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: absence of evidence for purifying selection in somatic mitochondrial DNA point mutations.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12887_27_23166522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B40754CC-B3E8-40BA-AD25-E9DDFD5EEC9A</gtr:id><gtr:title>Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f2ae3b1db951873a152282b9dd26a0"><gtr:id>31f2ae3b1db951873a152282b9dd26a0</gtr:id><gtr:otherNames>Ehinger JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d676c2e5364.34364290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2232BB9-581A-4A86-A88E-B2BC06675A5E</gtr:id><gtr:title>Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc1e6261a073e8c97bb04481b8202a"><gtr:id>a3bc1e6261a073e8c97bb04481b8202a</gtr:id><gtr:otherNames>Taylor RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_540e15ee15e96155b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4DE813A-B45D-4F1C-9869-3FFF8851AA23</gtr:id><gtr:title>Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd55d049dbcc0d328614887ca48f1222"><gtr:id>fd55d049dbcc0d328614887ca48f1222</gtr:id><gtr:otherNames>Martikainen MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>57c01a107b5a57.61431528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E17308B-C9C5-4D38-8AD5-B101E98FF6E0</gtr:id><gtr:title>Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79450e4524dd6bf57d1eea3282e0deab"><gtr:id>79450e4524dd6bf57d1eea3282e0deab</gtr:id><gtr:otherNames>Sommerville EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5a5f5577cfc704.99990620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6ECE407-0118-44EC-BCF4-29AD115A2C8D</gtr:id><gtr:title>Discrete gait characteristics are associated with m.3243A&amp;gt;G and m.8344A&amp;gt;G variants of mitochondrial disease and its pathological consequences.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8894fd431814e7b0d5213d0aae4975a7"><gtr:id>8894fd431814e7b0d5213d0aae4975a7</gtr:id><gtr:otherNames>Galna B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>544e59c648c850.33353731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12158CCA-A126-4167-A821-A1FC08E5F02F</gtr:id><gtr:title>The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A&amp;gt;G mutation--implications for diagnosis and management.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f5a64e763cce75d1f562606ee76e5bc"><gtr:id>7f5a64e763cce75d1f562606ee76e5bc</gtr:id><gtr:otherNames>Nesbitt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_13312_22_23355809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24671D21-838D-43B8-ADE5-D3BB3581CCA2</gtr:id><gtr:title>Repeats, longevity and the sources of mtDNA deletions: evidence from 'deletional spectra'.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdf431c05dc17295525a1856a93bf8a"><gtr:id>1bdf431c05dc17295525a1856a93bf8a</gtr:id><gtr:otherNames>Guo X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>dqaarMpE66V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8247600A-45C0-4F58-B772-6E908820FD46</gtr:id><gtr:title>A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92036d9b29125add13836e8d7b90148b"><gtr:id>92036d9b29125add13836e8d7b90148b</gtr:id><gtr:otherNames>Rocha MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56e1496af0df48.77525286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B7965C-DCD4-4C6B-8769-801CA40A8AAF</gtr:id><gtr:title>Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af0e1f2f14544e38f79ba0aa8f8d588c"><gtr:id>af0e1f2f14544e38f79ba0aa8f8d588c</gtr:id><gtr:otherNames>Krishnan KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12887_27_21925769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>719F216F-9223-4E98-911B-7C6BC4E9444B</gtr:id><gtr:title>Prevalence and architecture of de novo mutations in developmental disorders.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fd4d480801d072e0ab142663a0736f4"><gtr:id>3fd4d480801d072e0ab142663a0736f4</gtr:id><gtr:otherNames>Deciphering Developmental Disorders Study</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa2a046ac0af1.47338807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>555B4B8F-4A80-4EAA-A650-43584303F412</gtr:id><gtr:title>The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple families.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9015226fe85aa441230a01ec3c9484"><gtr:id>fe9015226fe85aa441230a01ec3c9484</gtr:id><gtr:otherNames>Tuppen HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>jqsLm6yhQ9s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3093DCF3-9D86-426E-B4D2-183170429331</gtr:id><gtr:title>Mitochondrial mutations: newly discovered players in neuronal degeneration.</gtr:title><gtr:parentPublicationTitle>The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-8584</gtr:issn><gtr:outcomeId>pm_12887_27_22130639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>946F2129-4673-492D-AC21-96659B097202</gtr:id><gtr:title>Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e2d81b8ea001d9cb0929e98392bea50"><gtr:id>6e2d81b8ea001d9cb0929e98392bea50</gtr:id><gtr:otherNames>Limongelli G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>XrqdnBXQJTE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A406987E-9A4F-4466-90E2-CF4B469732A6</gtr:id><gtr:title>Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac9010b8fd67e4b517628ed4d73c5ab"><gtr:id>7ac9010b8fd67e4b517628ed4d73c5ab</gtr:id><gtr:otherNames>Chrysostomou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>57c01a111932a4.21292692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A369458C-3D4A-4FD9-995C-95DF3AB1D228</gtr:id><gtr:title>Loss of myelin-associated glycoprotein in kearns-sayre syndrome.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_12887_27_22491194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC717DB-8794-43F0-AFFE-FC1D900E8306</gtr:id><gtr:title>Mitochondrial tRNA mutations and disease.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. RNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d934800bba4c6d737acf332a3f88b99e"><gtr:id>d934800bba4c6d737acf332a3f88b99e</gtr:id><gtr:otherNames>Yarham JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-7004</gtr:issn><gtr:outcomeId>pm_12887_27_21935892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8D3F8E5-2D36-4AA1-8BE3-A4077BABAE35</gtr:id><gtr:title>NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_13312_22_23746447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F152ED2-9FCC-4E12-ADE6-734D73306DCB</gtr:id><gtr:title>OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f10cd57acff5bf672c59111d788d8f"><gtr:id>e1f10cd57acff5bf672c59111d788d8f</gtr:id><gtr:otherNames>White KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>01F39F29BED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59A36035-AF2E-4EA9-A4E4-65AB8142CF8C</gtr:id><gtr:title>The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f950fd99d3923d0e32eb2c63f89184e9"><gtr:id>f950fd99d3923d0e32eb2c63f89184e9</gtr:id><gtr:otherNames>Fratter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>cBvg9gBkyEh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4226013-D4B7-4021-806E-13D1E6EC24BB</gtr:id><gtr:title>Mitochondrial Donation - Clearing the Final Regulatory Hurdle in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341f0d561136c211aae3d422891fb72"><gtr:id>a341f0d561136c211aae3d422891fb72</gtr:id><gtr:otherNames>Herbert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5a5f5578674750.83640193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03E1F314-DA24-4F3D-85E2-CFDF1A7F8125</gtr:id><gtr:title>The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4767d613694b160a2224099a0d07c0e9"><gtr:id>4767d613694b160a2224099a0d07c0e9</gtr:id><gtr:otherNames>Ng YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>5a35e49ead6b00.23069463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE805CB5-8C63-4796-ACC7-F99D710E9E5A</gtr:id><gtr:title>Kearns-Sayre syndrome caused by defective R1/p53R2 assembly.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_13312_22_21378381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B50C6B5-0254-49BE-B315-FA860319B7EE</gtr:id><gtr:title>Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>tjajB5EAgMp</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800674</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>